As cytotoxic treatment has often been reported to enrich BCSCs (39), as expected, Linc00668 expression was elevated in Dox resistant breast cancer cells and forced expression of Linc00668 promoted the development of the resistance to Dox. The gene discussed is LINC00668; the disease is breast carcinoma.